Abstract:Background Photothermal therapy (PTT) is a highly effective treatment for solid tumors and can induce long-term immune memory worked like an in situ vaccine. Nevertheless, PTT inevitably encounters photothermal resistance of tumor cells, which hinders therapeutic effect or even leads to tumor recurrence. Naïve CD8+ T cells are mainly metabolized by oxidative phosphorylation (OXPHOS), followed by aerobic glycolysis after activation. And the differentiate of effector CD8+ T cell (CD8+ T eff ) into central memory CD8+ T cell (CD8+ TCM) depends on fatty acid oxidation (FAO) to meet their metabolic requirements, which is regulated by adenosine monophosphate activated protein kinase (AMPK). In addition, the tumor microenvironment (TME) is severely immunosuppressive, conferring additional protection against the host immune response mediated by PTT. Methods Metformin (Met) down-regulates NADH/NADPH, promotes the FAO of CD8+ T cells by activating AMPK, increases the number of CD8+ TCM, which boosts the long-term immune memory of tumor-bearing mice treated with PTT. Here, a kind of PLGA microspheres co-encapsulated hollow gold nanoshells and Met (HAuNS-Met@MS) was constructed to inhibit the tumor progress. 2-Deoxyglucose (2DG), a glycolysis inhibitor for cancer starving therapy, can cause energy loss of tumor cells, reduce the heat stress response of tumor cell, and reverse its photothermal resistance. Moreover, 2DG prevents N-glycosylation of proteins that cause endoplasmic reticulum stress (ERS), further synergistically enhance PTT-induced tumor immunogenic cell death (ICD), and improve the effect of immunotherapy. So 2DG was also introduced and optimized here to solve the metabolic competition among tumor cells and immune cells in the TME. Results We utilized mild PTT effect of HAuNS to propose an in situ vaccine strategy based on the tumor itself. By targeting the metabolism of TME with different administration strategy of 2DG and perdurable action of Met, the thermotolerance of tumor cells was reversed, more CD8+ TCMs were produced and more effective anti-tumor was presented in this study. Conclusion The Step-by-Step starving-photothermal therapy could not only reverse the tumor thermotolerance, but also enhance the ICD and produce more CD8+ TCM during the treatment. Graphical Abstract

Lysosomal Activable Vorinostat Carrier-Prodrug Self-Assembling with BPQDs Enables Photothermal Oncotherapy to Reverse Tumor Thermotolerance and Metastasis.

Polymerized Vorinostat Mediated Photodynamic Therapy Using Lysosomal Spatiotemporal Synchronized Drug Release Complex

Lysosome activable polymeric vorinostat encapsulating PD-L1KD for a combination of HDACi and immunotherapy

Self-Delivery Nanomedicines Reverse Thermal Resistance to Enhance Tumor Mild-Temperature Photothermal Therapy

Hyaluronic Acid-Functionalized Polydopamine Nanoparticles Augment Photothermal Therapy via Synergetic Tumor-Targeting and Heat Shock Protein Inhibition

A biotin-modified and H<sub>2</sub>O<sub>2</sub>-activatable theranostic nanoplatform for enhanced photothermal and chemical combination cancer therapy

Biodegradable black phosphorus-based nanospheres for in vivo photothermal cancer therapy

Gelated Vorinostat with Inner-Lysosome Triggered Release for Tumor-Targeting Chemotherapy.

A dual-prodrug nanogel combining Vorinostat and Pyropheophorbide a for a high efficient photochemotherapy

Polydopamine-encapsulated zinc peroxide nanoparticles to target the metabolism-redox circuit against tumor adaptability for mild photothermal therapy

Bortezomib-Encapsulated CuS/Carbon Dot Nanocomposites for Enhanced Photothermal Therapy Via Stabilization of Polyubiquitinated Substrates in the Proteasomal Degradation Pathway

Redox-activatable photothermal therapy and enzyme-mediated tumor starvation for synergistic cancer therapy

NIR-controlled HSP90 Inhibitor Release from Hollow Mesoporous Nanocarbon for Synergistic Tumor Photothermal Therapy Guided by Photoacoustic Imaging

Peptide-IR820 Conjugate: A Promising Strategy for Efficient Vascular Disruption and Hypoxia Induction in Melanoma

Intracellular Nanoparticle Formation and Hydroxychloroquine Release for Autophagy‐Inhibited Mild‐Temperature Photothermal Therapy for Tumors

Cooperatively Enhanced Photothermal-Chemotherapyviasimultaneously Downregulating HSPs and Promoting DNA Alkylation in Cancer Cells

Polypeptide nanoparticles conjugated with an NIR-II organic dye for TRPV1 channel blockade enhance mild phototheranostics

In Vivo Imaging-Guided Photothermal/Photoacoustic Synergistic Therapy with Bioorthogonal Metabolic Glycoengineering-Activated Tumor Targeting Nanoparticles

Stable Black Phosphorus Nanosheets Exhibiting High Tumor-Accumulating and Mitochondria-Targeting for Efficient Photothermal Therapy Via Double Functionalization.

Regulating Immune Memory and Reversing Tumor Thermotolerance Through a Step-by-Step Starving-Photothermal Therapy

Vanadyl Nanocomplexes Enhance Photothermia-Induced Cancer Immunotherapy to Inhibit Tumor Metastasis and Recurrence